Pathogenesis of coxsackievirus A9 in mice: role of the viral arginine-glycine-aspartic acid motif

References

1. Acharya R., Fry E., Stuart D., Fox G., Rowlands D., Brown F. 1989; The three-dimensional structure of foot-and-mouth disease virus at 2·9 Å resolution. Nature 337:709–716
   [Google Scholar]
2. Baranowski E., Ruiz-Jarabo C. M., Sevilla N., Andreu D., Beck E., Domingo E. 2000; Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in apthovirus receptor usage. J Virol 74:1641–1647
   [Google Scholar]
3. Blaschuk K. L., Guerin C., Holland P. C. 1997; Myoblast α _V β ₃ integrin levels are controlled by transcriptional regulation of expression of the β ₃ subunit and down-regulation of β ₃ subunit expression is required for skeletal muscle cell differentiation. Dev Biol 184:266–277
   [Google Scholar]
4. Boonyakiat Y., Hughes P. J., Ghazi F., Stanway G. 2001; Arginine-glycine-aspartic acid motif is critical for human parechovirus 1 entry. J Virol 75:10000–10004
   [Google Scholar]
5. Buckley C. D., Pilling D., Henriquez N. V. 7 other authors 1999; RGD peptides induce apoptosis by direct caspase-3 activation. Nature 397:534–539
   [Google Scholar]
6. Chang K. H., Auvinen P., Hyypiä T., Stanway G. 1989; The nucleotide sequence of coxsackievirus A9: implications for receptor binding and enterovirus classification. J Gen Virol 70:3269–3280
   [Google Scholar]
7. Chang K. H., Day C., Walker J., Hyypiä T., Stanway G. 1992; The nucleotide sequence of wild-type coxsackievirus A9 strains imply that an RGD motif in VP1 is functionally significant. J Gen Virol 73:621–626
   [Google Scholar]
8. Chiu C. Y., Mathias P., Nemerow G. R., Stewart P. L. 1999; Structure of adenovirus complexed with its internalization receptor, α _v β ₅ integrin. J Virol 73:6759–6768
   [Google Scholar]
9. Forss S., Strebel K., Beck E., Schaller H. 1984; Nucleotide sequence and genome organization of foot-and-mouth disease virus variant. Nucleic Acids Res 12:6587–6601
   [Google Scholar]
10. Fox G., Parry N. R., Barnett P. V., McGinn B., Rowlands D. J., Brown F. 1989; The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). J Gen Virol 70:625–637
    [Google Scholar]
11. Grist N. R., Reid D. 1988; General pathogenicity and epidemiology. In Coxsackieviruses, A General Update pp  221–239 Edited by Berdinelli M., Friedman H. New York: Plenum;
    [Google Scholar]
12. Harvala H., Kalimo H., Dahllund L., Santti J., Hughes P., Hyypiä T., Stanway G. 2002; Mapping of tissue tropism determinants in coxsackievirus genomes. J Gen Virol 83:1697–1706
    [Google Scholar]
13. Hovi T., Stenvik M., Rosenlew M. 1996; Relative abundance of enterovirus serotypes in sewage differs from that in patients: clinical and epidemiological implications. Epidemiol Infect 116:91–97
    [Google Scholar]
14. Hughes P. J., Horsnell C., Hyypiä T., Stanway G. 1995; The coxsackievirus A9 RGD motif is not essential for virus viability. J Virol 69:8035–8040
    [Google Scholar]
15. Hyypiä T., Horsnell M., Maaronen M., Khan M., Kalkkinen N., Auvinen P., Kinnunen L., Stanway G. 1992; A distinct picornavirus group identified by sequence analysis. Proc Natl Acad Sci U S A 89:8847–8851
    [Google Scholar]
16. Hyypiä T., Kallajoki M., Maaronen M., Stanway G., Kandolf R., Auvinen P., Kalimo H. 1993; Pathogenetic differences between coxsackie A and B virus infections in newborn mice. Virus Res 27:71–78
    [Google Scholar]
17. Jackson T., Blakemore W., Newman J. W. I., Knowles N. J., Mould A. P., Humphries M. J., King A. M. Q. 2000a; Foot-and-mouth disease virus is a ligand for the high-affinity binding conformation of integrin α ₅ β ₁: influence of the leucine residue within the RGDL motif on selectivity of integrin binding. J Gen Virol 81:1383–1391
    [Google Scholar]
18. Jackson T., Sheppard D., Denyer M., Blakemore W., King A. M. Q. 2000b; The epithelial integrin α _V β ₆ is a receptor for foot-and-mouth disease virus. J Virol 74:4949–4956
    [Google Scholar]
19. Menko A. S., Boettiger D. 1987; Occupation of the extracellular matrix receptor, integrin, is a control point myogenic differentiation. Cell 51:51–57
    [Google Scholar]
20. Neff S., Sá-Carvalho D., Rieder E., Mason P. W., Blystone S. D., Brown E. J., Baxt B. 1998; Foot-and-mouth disease virus virulent for cattle utilizes the integrin α _V β ₃ as its receptor. J Virol 72:3587–3594
    [Google Scholar]
21. Nelsen-Salz B., Eggers H. J., Zimmermann H. 1999; Integrin α _V β ₃ (vitronectin receptor) is a candidate receptor for the virulent echovirus 9 strain Barty. J Gen Virol 80:2311–2313
    [Google Scholar]
22. Paananen A., Ylipaasto P., Rieder E., Hovi T., Galama J., Roivainen M. 2003; Molecular and biological analysis of echovirus 9 strain isolated from a diabetic child. J Med Virol 69:529–537
    [Google Scholar]
23. Pulli T., Lankinen H., Roivainen M., Hyypiä T. 1998a; Antigenic sites of coxsackievirus A9. Virology 240:202–212
    [Google Scholar]
24. Pulli T., Roivainen M., Hovi T., Hyypiä T. 1998b; Induction of neutralizing antibodies by synthetic peptides representing the C terminus of coxsackievirus A9 capsid protein VP1. J Gen Virol 79:2249–2253
    [Google Scholar]
25. Roivainen M., Hyypiä T., Piirainen L., Kalkkinen N., Stanway G., Hovi T. 1991; RGD-dependent entry of coxsackievirus A9 into host cell and its bypass after cleavage of VP1 protein by intestinal proteases. J Virol 65:4735–4740
    [Google Scholar]
26. Roivainen M., Piirainen L., Hovi T., Virtanen I., Riikonen T., Heino J., Hyypiä T. 1994; Entry of coxsackievirus A9 into host cells: specific interactions with α _v β ₃ integrin, the vitronectin receptor. Virology 203:357–365
    [Google Scholar]
27. Ruoslahti E., Reed J. 1999; New way to activate caspases. Nature 397:479–480
    [Google Scholar]
28. Santti J., Harvala H., Kinnunen L., Hyypiä T. 2000; Molecular epidemiology and evolution of coxsackievirus A9. J Gen Virol 81:1361–1372
    [Google Scholar]
29. Stanway G., Kalkkinen N., Roivainen M., Ghazi F., Khan M., Smyth M., Meurman O., Hyypiä T. 1994; Molecular and biological characteristics of echovirus 22, a representative of a new picornavirus group. J Virol 68:8232–8238
    [Google Scholar]
30. Triantafilou M., Triantafilou K., Wilson K. M., Takada Y., Fernandez N. 2000; High affinity interactions of coxsackievirus A9 with integrin α _V β ₃ (CD51/61) require the CYDMKTTC sequence of β ₃, but do not require the RGD sequence of the CAV-9 VP1 protein. Hum Immunol 61:453–459
    [Google Scholar]
31. Zimmermann H., Eggers H. J., Nelsen-Salz B. 1996; Molecular cloning and sequence determination of the complete genome of the virulent echovirus 9 strain Barty. Virus Genes 12:149–154
    [Google Scholar]
32. Zimmermann H., Eggers H. J., Nelsen-Salz B. 1997; Cell attachment and mouse virulence of echovirus 9 correlate with an RGD motif in the capsid protein VP1. Virology 233:149–156
    [Google Scholar]